Uterine | Maryland Oncology Hematology Uterine – Maryland Oncology Hematology

Trial ID ESR 22-21698 (EIMPRIS)

clinicaltrials.gov ID
Phase II/III

Trial ID 21271

clinicaltrials.gov ID
USOR ID: 21271 Phase II
A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma

Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology